Vaxigrip: Side Effects & Dosing

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Inactivated trivalent flu vaccine (split virion)

Indications/Uses

Active immunisation of adults, including pregnant women & childn from ≥6 mth for prevention of flu caused by 2 influenza A virus subtypes & influenza B virus type.

Click to view Vaxigrip detailed prescribing information

Dosage/Direction for Use

IM/SC Adult & childn 6 mth-17 yr 1 dose of 0.5 mL. Childn <9 yr who have not been previously vaccinated 2nd dose of 0.5 mL given after at least 4 wk interval.

Click to view Vaxigrip detailed prescribing information

Overdosage

View Vaxigrip overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to inactivated trivalent flu vaccine or to any component that may be present as traces eg, eggs (ovalbumin, chicken proteins), neomycin, formaldehyde & octoxinol-9.

Click to view Vaxigrip detailed prescribing information

Special Precautions

Appropriate medical treatment & supervision should always be readily available in case of anaphylactic reaction following vaccine administration. Postpone vaccination in case of moderate or severe febrile or acute disease. Not to be administered intravascularly. Patients w/ thrombocytopenia or bleeding disorder; bleeding may occur following IM administration. Syncope may occur following or before any vaccination; put procedures in place to prevent injury from fainting & manage syncopal reactions. May not protect all vaccinees. Possible insufficient Ab response in patients w/ endogenous or iatrogenic immunosuppression. Contains <1 mmol/dose K & Na. Not all infants <6 mth born to vaccinated women during pregnancy will be protected.

Click to view Vaxigrip detailed prescribing information

Use In Pregnancy & Lactation

Click to view Vaxigrip detailed prescribing information

Adverse Reactions

Headache; myalgia; inj site pain, malaise. Fever, shivering, inj site erythema, induration & swelling. Childn 3-17 yr & 6-35 mth: Inj site ecchymosis. Childn 6-35 mth: Decreased appetite; abnormal crying, irritability; drowsiness; vomiting. Diarrhea.

Click to view Vaxigrip detailed prescribing information

Drug Interactions

Not to be given at the same time as other vaccines; use separate inj site & syringes. Immunological response may be reduced w/ immunosuppressant treatment.

Click to view Vaxigrip detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Vaxigrip detailed prescribing information

Storage

View Vaxigrip storage conditions for details to ensure optimal shelf-life.

Description

View Vaxigrip description for details of the chemical structure and excipients (inactive components).

Action

View Vaxigrip mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.

Regulatory Classification

POM

Presentation/Packing

Form

Vaxigrip susp for inj 0.5 mL

Packing/Price

1's

Vaxigrip

influenza vaccine

Manufacturer:

sanofi pasteur

Distributor:

DKSH